Poster Abstract Session:
246. HIV and Women
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Adult ID, HIV-STD-TB, Investigative ID, Trainee


Presentations:
Prevalence of Drug-drug Interactions with Hormonal Contraceptives and Antiretrovirals in Women Living with HIV
Milena M. McLaughlin, PharmD, MSc; Ashley Jensen, BS; Susan Cohn, MD, MPH; Kristin Darin, PharmD
Safety and Tolerability of High Dose Atazanavir/ritonavir and Lopinavir/ritonavir in Pregnant Women Living with Human Immunodeficiency Virus
Milena M. McLaughlin, PharmD, MSc; Colleen Blackshear, PharmD; Joel Hernandez, PharmD Candidate; Gergana Ivanova, PharmD Candidate; Lana Gerzenshtein, PharmD; Kimberly Scarsi, PharmD
Comparison of two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV-) Infected Pregnant Women
Danielle Tate, MD; Fernand Samson, MD; Mary Christiansen, MD; Lindsay Meyers, MD; Kitty Cashion, RN, MSN; Jenny Wang, MD; Marina Santa Cruz, MD; Luis Gomez, MD
Posters
  • ID week Poster Final.pdf (298.7 kB)
  • Prevalence and Risk Factors for Intimate Partner Violence in Women Living with HIV in Uganda
    Cynthia R. Young, MD, MSc; Angela Kaida, PhD; Jerome Kabakyenga, PhD; Winnie Muyindike, MBChB, MMED; Jeffery N. Martin, MD, MPH; Peter W. Hunt, MD; David R. Bangsberg, MD, MPH; Jessica E. Haberer, MD, MS; Lynn T. Matthews, MD, MPH
    Effective Contraceptive Use Following Unplanned Pregnancy Among Ugandan Women Living with HIV
    Jana Jarolimova, MD; Kara Bennett, MSc; Jerome Kabakyenga, PhD; Jeffery N. Martin, MD, MPH; Peter Hunt, MD; Jessica E. Haberer, MD, MS; David R. Bangsberg, MD, MPH; Angela Kaida, PhD; Lynn T. Matthews, MD, MPH

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.